Metabolomic Profiling of Patients With Traumatic Brain Injury
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorDr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
About this trial
Traumatic Brain Injury (TBI) is a significant cause of mortality and morbidity worldwide. However, the literature on determining its severity and predicting prognosis is insufficient. This study aimed to examine the differences in metabolite levels between trauma patients with severe TBI and orthopedic trauma patients without brain injury.
Eligibility criteria
Qualifiers
Ages 18-65
Patients diagnosed with severe TBI clinically or according to National Institute for Health and Care Excellence (NICE) criteria (including post-traumatic imaging)
Patients with non-TBI orthopedic or multitrauma
Disqualifiers
Presence of brain pathology in the pre-trauma period
Patient with chronic subdural hematoma
Trial design
Treatments tested in this trial
- Not listed
Trial groups
60 Participants
are grouped into 2 trial groupsLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Aksaray UniversityRecruiting06810, Aksaray, AnkaraTurkey (Türkiye)
Sponsors and collaborators
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Lead sponsor
Aksaray University Training and Research Hospital
Sponsor institution
Source ClinicalTrials.gov